ClinicalThought

Share

Program Content

Activities

  • CLL Molecular Considerations
    How I Adapt CLL Treatment to Evolving Molecular Considerations
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: August 09, 2016

    Expires: August 08, 2017

  • Treating Fit Patients With CLL
    How I Treat Young, Fit Patients With Newly Diagnosed Non-del(17p) CLL
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: September 29, 2016

    Expires: September 28, 2017

  • Relapsed del(17p) CLL
    What Is the Optimal Treatment for Patients With Relapsed del(17p) CLL?
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: October 31, 2016

    Expires: October 30, 2017

  • Assessing <i>IgHV</i> Mutations in CLL
    Should You Use IgHV Mutation Status to Select Optimal Choice of Therapy for Your Patients With CLL?
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: November 16, 2016

    Expires: November 15, 2017

  • ASH 2016 Ibrutinib in CLL
    CLL Studies Presented at the 2016 Hematology Meeting Confirm Ibrutinib’s Long-term Efficacy and Suggest Benefit From Second-line Agents
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: January 06, 2017

    Expires: January 05, 2018

  • Ibrutinib-Refractory Non-del(17p) CLL
    How I Manage Ibrutinib-Refractory Patients With CLL Without Del(17p)
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: April 13, 2017

    Expires: April 12, 2018

  • Maintenance Therapy in CLL
    What Is the Role of Maintenance Therapy in CLL?
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: May 16, 2017

    Expires: May 15, 2018

  • Top 5 Abstracts in CLL
    ASCO 2017: My Top 5 Most Interesting CLL Abstracts
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 22, 2017

    Expires: June 21, 2018

Faculty

cover img faculity

Farrukh Awan, MD, MS

Associate Professor of Internal Medicine
Division of Hematology
The Ohio State University Comprehensive Cancer Center
Arthur G. James Cancer Hospital and Richard J. Solove Research Institute
Columbus, Ohio

cover img faculity

John M. Burke, MD

Associate Chair
US Oncology Hematology Research Program
Rocky Mountain Cancer Centers
Aurora, Colorado

cover img faculity

Jeffrey P. DONOTUSESharman, MD

Medical Oncologist
Willamette Valley Cancer Institute and Research Center
Springfield, Oregon

cover img faculity

Jeff DONOTUSESharman, MD

Medical Director of Hematology Research
Willamette Valley Cancer Institute
US Oncology
Eugene, Oregon

cover img faculity

Jeffrey A. Jones, MD, MPH

Associate Professor of Medicine
Section Head of CLL/HCL
Division of Hematology
The Ohio State University
Columbus, Ohio

cover img faculity

Andrew D. Zelenetz, MD, PhD

Associate Professor, Department of Medicine
Cornell University Medical College
Chief, Lymphoma Service
Memorial Sloan-Kettering Cancer Center
New York, New York

Provided by

ProCE Banner

Supporters

AbbVie

Genentech Roche Virology

Janssen Pharmacyclics

Pharmacyclics Inc